Clinical Trial Update: Severe Bullous Drug Eruption and Filgrastim [Phase 2, Phase 3]

View source ↗

Summary

The document announces ongoing Phase 2 and Phase 3 recruitment for a clinical trial evaluating filgrastim in patients with toxic epidermal necrolysis, a severe …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Toxic Epidermal Necrolysis

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Rare Diseases, Toxic Epidermal Necrolyses | Phase 2, Phase 3 | Status: RECRUITING